Brevetti EPO No.3880678 2025.05.07
Brevetti EPO
(10) Registration Number and Date
2025000237 2025.06.27
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2025/000237 2019.11.12
(40) Publication Number and Date
SM /T/2025/000237 2025.06.27
(30) Priority Details
US 201862760307 P
2018.11.13
(71/73) Applicant
(IT) GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3)LIMITED : GSK Medicines Research CentreGunnels Wood Road, Stevenage SG1 2NY, GB
(72) Inventor
(IT) CHAURET, Nathalie : 275, Boulevard Armand-frappier, Laval, QC H7V 4A7, CA
(IT) GARCEAU, Denis : 275, Boulevard Armand-frappier, Laval, QC H7V 4A7, CA
(IT) WENSLOW, Robert M. : 275, Boulevard Armand-frappier, Laval, QC H7V 4A7, CA
(IT) PAYZA, Kemal : 275, Boulevard Armand-frappier, Laval, QC H7V 4A7, CA
(74) Representative Name
(IT) DE BENEDETTI, Jacopo : Via L. Cibrario, 25, 47893 Borgo Maggiore RSM , SM
(54) Title
(IT) FORME CRISTALLINE DI MODULATORE DI P2X3 METIL (S)-2-((2-(2,6-DIFLUORO-4-(METILCARBAMOIL)FENIL)-7-METILIMIDAZO[1,2-A]PIRIDIN-3-IL)METIL)MORFOLINA-4-CARBOSSILATO
(EN) CRYSTALLINE FORMS OF P2X3 MODULATOR METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLINE-4-CARBOXYLATE
(57) Abstract
(58) Citations